Puma Biotechnology, Inc.
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Biotechnology
Latest on Puma Biotechnology, Inc.
A player in the oncology field since 1978, Pierre Fabre has been busy this month advancing its cancer ambitions through a pact with Vernalis (R&D) Ltd. and the acquisition of Vertical Bio . The F
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. NeuroBo Will Help Advance Dong-A Candid
The Follow-On Drug Era The period of pharmaceutical development known as the “me-too drug” or “follow-on drug” era was not the most auspicious for the sector. One pharmaceutical company’s small molecu
James Xue was an formerly executive with Genzyme in Boston and later became the China representative for the rare disease specialist before its acquisition by Sanofi . He founded CANbridge Pharmaceu